The Center for Pharmaceutical Research (CPR) is a privately owned clinical research center specializing in Phase I, II, III, and IV clinical trials for the pharmaceutical, nutraceutical, and medical device industries.
CPR has two primary missions, each equally important: to provide ethical, safe, cutting-edge medical care for our volunteers and high-quality, clean data to our sponsors with strict adherence to GCP guidelines.
John E. Ervin, MD, FACP, FACR founded The Center for Pharmaceutical Research in 1986, and serves as the CEO, Medical Director, and Principal Investigator.
The Center for Pharmaceutical Research was audited by the FDA in 1995, 2010, 2013, and 2015 with no findings and no 483’s issued. Since its inception, CPR has conducted more than 700 trials in most areas of multispecialty research.
Acid Reflux
Allergy
Asthma
Bio-Terrorism Vaccines
BPH
Cancer Vaccines
Constipation
Dermatology
Diabetes
DPN
Erectile Dysfunction
Female Sexual Dysfunction
Fibromyalgia
High Cholesterol/Lipids
Hypertension
Insomnia
Men’s Health
Migraine
Nephrology
Obesity
Oral Contraceptive
Orthopedics
Osteoarthritis
Pediatrics
Pediatric Vaccines
Phase I Vaccines
PHN
Premature Ejaculation
Psoriasis
Respiratory
Rheumatoid Arthritis
Rosacea
Seasonal Allergies
Sleep Disorders
Smoking Cessation
Urology
Vaccines
Women’s Health
Director of Business Development
Center for Pharmaceutical Research
Kansas City, Missouri